Impact of drugs on survival of patients with non-muscle invasive urothelial carcinoma of the bladder and patients after radical cystectomy.

Recruiting

• Conditions: C67; Malignant neoplasm of bladder

• Registration Number: DRKS00017080
• Lead Sponsor: rologische Klinik und PoliklinikKlinikum der Universität München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Patients with primary diagnosis urinary bladder cancer and patients with planned radical cystectomy;
Patients that are able to give consent and information on their medication.

Exclusion Criteria

Known metastasis at the time of study inculsion.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
cancer specific survival and progression free survival. Collected every 3 month during follow-up (interview via telephone with patient or relatives), medical records from urologic check-up by GP

Secondary Outcome Measures

Name	Time	Method
overall survival. Collected every 3 month during follow-up (interview via telephone with patient or relatives)